Form 8-K - Current report:
SEC Accession No. 0001213900-20-042389
Filing Date
2020-12-14
Accepted
2020-12-14 07:18:42
Documents
6
Period of Report
2020-12-10
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea131480-8k_aytubioscience.htm 8-K 36006
2 AMENDED AND RESTATED UNDERWRITING AGREEMENT, DATED DECEMBER 10, 2020, BETWEEN AY ea131480ex1-1_aytubio.htm EX-1.1 217069
3 FORM OF UNDERWRITER WARRANTS ea131480ex4-1_aytubio.htm EX-4.1 83458
4 OPINION OF DORSEY & WHITNEY LLP ea131480ex5-1_aytubio.htm EX-5.1 13870
5 PRESS RELEASE DATED DECEMBER 10, 2020 ea131480ex99-1_aytubio.htm EX-99.1 14042
6 PRESS RELEASE DATED DECEMBER 10, 2020 ea131480ex99-2_aytubio.htm EX-99.2 14620
  Complete submission text file 0001213900-20-042389.txt   380390
Mailing Address 373 INVERNESS PARKWAY SUITE 206 ENGLEWOOD CO 80112
Business Address 373 INVERNESS PARKWAY SUITE 206 ENGLEWOOD CO 80112 (720) 437-6580
AYTU BIOSCIENCE, INC (Filer) CIK: 0001385818 (see all company filings)

EIN.: 470883144 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38247 | Film No.: 201385084
SIC: 2834 Pharmaceutical Preparations